As partner at major InsurTech investor Anthemis, Ruth Foxe Blader explained to Insurance Insider why venture capitalists are pumping the brakes on InsurTech funding.
A long-awaited bill to reform regulatory oversight and impose a new growth duty on the watchdogs may fall short of the accountability measures hoped for.
